# EDGAR Filing Document

**Accession Number:** 0001944885
**File Stem:** 0001193125-23-048923
**Filing Date:** 2023-2
**Character Count:** 2220
**Document Hash:** d4c183dca733ebda3ec95f4809131640
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-048923.hdr.sgml**: 20230328

**ACCESSION NUMBER**: 0001193125-23-048923

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230224

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Apollomics Inc.
- **CENTRAL INDEX KEY:** 0001944885
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 989 EAST HILLSDALE BLVD.
- **STREET 2:** STE 220
- **CITY:** FOSTER CITY
- **STATE:** CA
- **ZIP:** 94404
- **BUSINESS PHONE:** 1-650-209-4055

**MAIL ADDRESS:**
- **STREET 1:** 989 EAST HILLSDALE BLVD.
- **STREET 2:** STE 220
- **CITY:** FOSTER CITY
- **STATE:** CA
- **ZIP:** 94404

**Apollomics Inc.** 

989 E. Hillsdale Blvd., Suite 220

Foster City, CA 94404

February 24, 2023

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attn: Tyler Howes

---

| | |
|:---|:---|
| **Re:** | **Apollomics Inc.**  |

---

**Registration Statement on Form F-4**

**Filed November 22, 2022, as amended**

**File No. 333-268525**

Dear Mr. Howes:

Pursuant to Rule 461 of the rules and regulations promulgated under the Securities Act of 1933, as amended, Apollomics Inc. respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. Washington D.C. time on February 28, 2023, or as soon thereafter as practicable.

Please call Daniel Nussen of White & Case LLP at (213) 620-7796 to provide notice of the effectiveness of the Registration Statement.

[*Signature Page Follows*] 

------

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **Apollomics Inc.** | **Apollomics Inc.** |
| By: | /s/ Guo-Liang Yu |
| Name:<br> Title: | Guo-Liang Yu <br>Chief Executive Officer and Chairman of the Board of Directors |

---

cc: Sanjeev Redkar, Apollomics Inc.

Brianna MacDonald, Apollomics Inc.

Daniel Nussen, White & Case LLP

James Hu, White & Case LLP